sulfobromophthalein has been researched along with ezetimibe in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fromm, MF; Giessmann, T; König, J; Kroemer, HK; Lütjohann, D; Oswald, S; Rimmbach, C; Rosskopf, D; Siegmund, W | 1 |
| Duthaler, U; Krähenbühl, S; Malagnino, V; Meyer Zu Schwabedissen, HE; Seibert, I | 1 |
1 trial(s) available for sulfobromophthalein and ezetimibe
| Article | Year |
|---|---|
Disposition of ezetimibe is influenced by polymorphisms of the hepatic uptake carrier OATP1B1.
Topics: Adult; Azetidines; Cells, Cultured; Ezetimibe; Female; Genotype; Humans; Inactivation, Metabolic; Liver; Liver-Specific Organic Anion Transporter 1; Male; Multidrug Resistance-Associated Protein 2; Organic Anion Transporters; Polymorphism, Single Nucleotide; Sterols; Sulfobromophthalein | 2008 |
1 other study(ies) available for sulfobromophthalein and ezetimibe
| Article | Year |
|---|---|
OATP1B3-1B7 (LST-3TM12) Is a Drug Transporter That Affects Endoplasmic Reticulum Access and the Metabolism of Ezetimibe.
Topics: Biological Transport; Catalytic Domain; Endoplasmic Reticulum, Smooth; Ezetimibe; Glucuronosyltransferase; HeLa Cells; Humans; Intestine, Small; Microsomes, Liver; Organic Anion Transporters; Solute Carrier Proteins; Sulfobromophthalein | 2019 |